Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
申请人:Brown R. Truman
公开号:US20060089316A1
公开(公告)日:2006-04-27
Disclosed are methods of using various compounds, which are known to bind to 3-deoxyglucosone (3DG) or precursors thereof, in order to reduce a susceptibility to tumor formation and/or to prevent or delay onset of tumor formation induced by 3DG and its precursors. Also disclosed is the reduction of 3DG levels in high fructose corn syrop so that the high fructose corn syrup is less likely to induce tumor formation.
NOVEL CARBONYL REDUCTASE, GENE THEREOF AND METHOD OF USING THE SAME
申请人:KANEKA CORPORATION
公开号:EP1553170A1
公开(公告)日:2005-07-13
The present invention provides a novel polypeptide efficiently forming (R)-N-benzyl-3-pyrrolidinol, a polynucleotide coding for said polypeptide, and use of the same.
The present invention relates to a polypeptide having the following physical and chemical properties (1) to (4):
(1) activity: acting on N-benzyl-3-pyrrolidinone with NADH or NADPH as a coenzyme, to form (R)-N-benzyl-3-pyrrolidinol;
(2) optimum pH for activity: 5.5 to 6.0;
(3) optimum temperature for activity: 50°C to 55°C;
(4) molecular weight: about 55,000 as determined by gel filtration analysis, about 28,000 as determined by SDS polyacrylamide gel electrophoresis analysis.
The present invention also relates to a polypeptide comprising the amino acid sequence shown under SEQ ID NO:1 in the sequence listing, a polynucleotide coding for said polypeptide, and a transformant producing said polypeptide at high levels.
CURABLE COMPOSITION AND CURED OBJECT FORMED THEREFROM
申请人:Kaneka Corporation
公开号:EP2388297A1
公开(公告)日:2011-11-23
The present invention aims to provide a curable composition that exhibits excellent curability without containing an organotin curing catalyst, which is known to be toxic, gives a cured product that does not have surface discoloration even after being exposed to the atmosphere and ultraviolet light for a long time, and has no adverse influence on the environment; and a cured product thereof. The non-organotin curable composition comprises: (A) an organic polymer having a reactive silyl group; (B) an amidine compound; and (C) a chelating agent having a carbonyl group and/or a salt of the chelating agent.